Adient plc
—- Market cap
- $1.54B
- Debt
- +$2.39B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 39% equity / 61% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $1.54B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 ·
Decision snapshot: ADNT stock price vs CPRX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CPRX's multiple
Needs CPRX P/S.
Implied fair value · at ADNT's multiple
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ADNT FY 2025 (ended Sep 30, 2025) · CPRX FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 39% equity / 61% debt
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Adient plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
CATALYST PHARMACEUTICALS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.35x
0.15x
Net debt / EBITDA
Leverage against operating earnings
—
-1.75x
Cash and equivalents
Liquid reserves on the balance sheet
—
$709.17M
Total debt
Interest-bearing obligations outstanding
$2.39B
$145.25M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMERICAN AXLE & MANUFACTURING HOLDINGS INC
ADNT vs AXL
VISTEON CORP
ADNT vs VC
DANA INC
ADNT vs DAN
BORGWARNER INC
ADNT vs BWA
FOX FACTORY HOLDING CORP
ADNT vs FOXF
Jazz Pharmaceuticals plc
ADNT vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
ADNT vs SUPN
PERRIGO Co plc
ADNT vs PRGO
Harmony Biosciences Holdings, Inc.
ADNT vs HRMY
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.